BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
- 1 October 2013
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 63, 175-179
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Place your BETs: the therapeutic potential of bromodomainsTrends in Pharmacological Sciences, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Protein Acetylation in the Cardiorenal AxisCirculation Research, 2010
- Positive Transcription Elongation Factor b Activity in Compensatory Myocardial Hypertrophy is Regulated by Cardiac Lineage Protein-1Circulation Research, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Cardiac PlasticityNew England Journal of Medicine, 2008
- Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophyCardiovascular Research, 2007
- The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent TranscriptionMolecular Cell, 2005
- Left Ventricular HypertrophyJAMA, 2004
- Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophyNature Medicine, 2002